- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Aminomethylbenzoic Acid is a type of hematological drug used to treat a variety of conditions, including anemia, thrombocytopenia, and neutropenia. It is a synthetic compound that is used to increase the production of red blood cells, platelets, and white blood cells. It is also used to treat certain types of cancer, such as leukemia and lymphoma. Aminomethylbenzoic Acid is available in both oral and intravenous forms.
The Aminomethylbenzoic Acid market is highly competitive, with many companies offering different formulations of the drug. Companies in the market include Pfizer, Novartis, Merck, and Bristol-Myers Squibb. These companies are involved in the research, development, and marketing of Aminomethylbenzoic Acid. Additionally, there are several generic manufacturers of the drug, such as Teva Pharmaceuticals and Mylan. Show Less Read more